Y.Flores-TrevioS.Bocanegra-IbariasP.Robles-EspinoD.Garza-GonzlezE.Fabela-ValdezG
C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
Gldener U, Heck S, Fiedler T, Beinhauer J, Hegemann JH
Not managing the conversation effectively may now prove to have been a strategic oversight given the reports of plateauing efficacy, which has payers and healthcare systems questioning the long-term cost-effectiveness of GLP-1s for either weight loss or type 2 diabetes, and tightening access
Moreover, when mice were pre-treated with vehicle or L2-Cmu (20 mg/kg) by intraperitoneal (i.p.) injection, and then challenged with an intravenous (i.v.) bolus of saline or 5 g IGF-1, L2-Cmu was able to modulate IGF-1R activation in vivo, as demonstrated by a near complete inhibition of IGF-1R phosphorylation in lung and ~70% inhibition in heart (Fig
